| BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence M Xing, R Liu, X Liu, AK Murugan, G Zhu, MA Zeiger, S Pai, J Bishop Journal of clinical oncology 32 (25), 2718-2726, 2014 | 792 | 2014 |
| TERT promoter mutations in thyroid cancer R Liu, M Xing Endocrine-related cancer 23 (3), R143-R155, 2016 | 454 | 2016 |
| TERT Promoter Mutations and Their Association with BRAF V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer X Liu, S Qu, R Liu, C Sheng, X Shi, G Zhu, AK Murugan, H Guan, H Yu, ... The Journal of Clinical Endocrinology & Metabolism 99 (6), E1130-E1136, 2014 | 363 | 2014 |
| JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells RY Liu, Y Zeng, Z Lei, L Wang, H Yang, Z Liu, J Zhao, HT Zhang International journal of oncology 44 (5), 1643-1651, 2014 | 330 | 2014 |
| Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: Genetic duet of BRAF and TERT promoter mutations in thyroid … R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson, M Xing Jama oncology 3 (2), 202-208, 2017 | 285 | 2017 |
| Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants X Shi, R Liu, F Basolo, R Giannini, X Shen, D Teng, H Guan, Z Shan, ... The Journal of Clinical Endocrinology & Metabolism 101 (1), 264-274, 2016 | 253 | 2016 |
| Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer R Liu, T Zhang, G Zhu, M Xing Nature Communications 9 (1), 579, 2018 | 175 | 2018 |
| The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer F Wang, X Yu, X Shen, G Zhu, Y Huang, R Liu, D Viola, R Elisei, ... The Journal of Clinical Endocrinology & Metabolism 102 (9), 3241-3250, 2017 | 116 | 2017 |
| The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer J Liu, R Liu, X Shen, G Zhu, B Li, M Xing Journal of Nuclear Medicine 61 (2), 177-182, 2020 | 115 | 2020 |
| Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, L Fugazzola, ... Journal of Clinical Oncology 36 (5), 438-445, 2018 | 112 | 2018 |
| Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy R Liu, M Xing Endocrine-related cancer 21 (5), 825-830, 2014 | 106 | 2014 |
| Association of TERT Promoter Mutation 1,295,228 C>T With BRAF V600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer X Shi, R Liu, S Qu, G Zhu, J Bishop, X Liu, H Sun, Z Shan, E Wang, Y Luo, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), E632-E637, 2015 | 102 | 2015 |
| A six-genotype genetic prognostic model for papillary thyroid cancer X Shen, R Liu, M Xing Endocrine-Related Cancer 24 (1), 41-52, 2017 | 85 | 2017 |
| BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment Y Huang, S Qu, G Zhu, F Wang, R Liu, X Shen, D Viola, R Elisei, ... JNCI: Journal of the National Cancer Institute 110 (4), 362-370, 2018 | 84 | 2018 |
| METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease Z Peng, Y Gong, X Wang, W He, L Wu, L Zhang, L Xiong, Y Huang, L Su, ... Molecular Therapy 30 (2), 932-946, 2022 | 75 | 2022 |
| CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer Z Liu, J Zhao, XF Chen, W Li, R Liu, Z Lei, X Liu, X Peng, K Xu, J Chen, ... Lung cancer 62 (1), 15-22, 2008 | 71 | 2008 |
| BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid Cancer F Wang, S Zhao, X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, ... Journal of Clinical Oncology 36 (27), 2787-2795, 2018 | 66 | 2018 |
| BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer Y Tao, F Wang, X Shen, G Zhu, R Liu, D Viola, R Elisei, E Puxeddu, ... The Journal of Clinical Endocrinology & Metabolism 106 (11), 3228-3238, 2021 | 59 | 2021 |
| Genetic variants in interleukin-6 modified risk of obstructive sleep apnea syndrome X Zhang, RY Liu, Z Lei, Y Zhu, JA Huang, X Jiang, Z Liu, X Liu, X Peng, ... International journal of molecular medicine 23 (4), 485-493, 2009 | 51 | 2009 |
| Identification and characterization of two novel oncogenic mTOR mutations AK Murugan, R Liu, M Xing Oncogene 38 (26), 5211-5226, 2019 | 43 | 2019 |
